Click the image below to listen to our most recent “Women & Pulmonary: Sleep in Women Across the Life Span” webinar
Click the image below to view “Women in Pulmonary: Gender Differences in Diagnosing and Treating Asthma, COPD, and ILD”
Sex and gender differences are poorly characterized in many aspects of lung development and disease. It is evident, nonetheless, that female sex and gender play a clear role in many aspects of lung physiology, biology, and pathologic condition. This role may translate into sex differences in disease susceptibility, presentation, severity, associated outcomes, and response to treatment. Pharmacodynamics and drug metabolism also differ by sex, with recommendations for different dosing regimens of certain drugs in female subjects.
Listen in as Dr. Joe Zein, Dr. Dawn Demeo, and Dr. Sonye Danoff discuss some of the key gender differences to be aware of when treating asthma, COPD, and ILD.
“Women in Pulmonary: Being an Advocate for Yourself”
The gender gap exists for women in pulmonary medicine. According to the Medscape Pulmonologist Compensation Report 2017, female pulmonologists earned 23% less than their male counterparts even though:
- Just 2% of female pulmonologists work part – time vs 8% of male pulmonologists
- More women (66%) than men (48%) reported seeking promotion
Despite ever-growing enrollment rates for women in medical school, female physicians are often underrepresented in academic and research settings, and according to the study, “Women on Professional Society and Journal Editorial Boards , ” published in the Journal of National Medical Association, “between 80 to 90 percent of leadership roles in medicine, like medical school deans, are filled by men.” Being an advocate for yourself can help close these gaps and help women across the globe achieve leadership roles, competitive pay and benefits, as well as work-life balance.
In this webinar, Aneesa Das, MD, FCCP, and Roozehra Khan, DO, FCCP, discuss these issues and give tips on how to be an advocate for yourself.
“Patient and Clinician Engagement in Treating Pulmonary Fibrosis”
Understanding where the patient is within their progression of pulmonary fibrosis, as well as any emotional barriers and stigmas, allows clinicians to treat the person rather than just the disease. Meeting patients where they are empowers them to speak directly about the concerns and issues they currently face. At the same time, chest medicine clinicians who have a more objective picture of their patients’ progression can tailor treatments and better create an atmosphere where patients are willing to engage and feel motivated to take charge of the management of pulmonary fibrosis.
With this clear understanding of discussing the best ways to bring together patients and clinicians for better engagement, CHEST Foundation, in partnership with Boehringer Ingelheim, presents this webinar on Patient and Clinician Engagement in Treating Pulmonary Fibrosis as a part of a three-part series. Other webinars in this series will address patient and clinician engagement related to COPD and asthma. This webinar will feature patient advocacy partners, clinicians, caregivers, and patients, and each will focus on how to create a planned discussion specific to each disease.